Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 23.69 billion as of May 1, 2025. Its market cap has decreased by -17.64% in one year.

Market Cap

23.69B

Enterprise Value

24.50B

Revenue

4.62B

Ranking

n/a

PE Ratio

1.03

Stock Price

10.92

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 23.69B, an increase of 1,021.49%. That is a compound annual growth rate of 29.54%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2025	23.69B	12.27%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	208.83B
Hansoh Pharmaceutical Group Company	143.29B
JD Health International	118.79B
WuXi Biologics	92.39B
Innovent Biologics	88.59B
Alibaba Health Information Technology	81.06B
Akeso	77.42B
Sichuan Kelun-Biotech Biopharmaceutical	75.63B

Market Cap Rankings